252 related articles for article (PubMed ID: 24648278)
1. Bone morphogenetic protein-2 antagonizes bone morphogenetic protein-4 induced cardiomyocyte hypertrophy and apoptosis.
Lu J; Sun B; Huo R; Wang YC; Yang D; Xing Y; Xiao XL; Xie X; Dong DL
J Cell Physiol; 2014 Oct; 229(10):1503-10. PubMed ID: 24648278
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
Sun B; Huo R; Sheng Y; Li Y; Xie X; Chen C; Liu HB; Li N; Li CB; Guo WT; Zhu JX; Yang BF; Dong DL
Hypertension; 2013 Feb; 61(2):352-60. PubMed ID: 23248151
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy.
Wang YC; Xiao XL; Li N; Yang D; Xing Y; Huo R; Liu MY; Zhang YQ; Dong DL
Br J Pharmacol; 2015 Dec; 172(23):5586-95. PubMed ID: 25323043
[TBL] [Abstract][Full Text] [Related]
4. Insulin prevents bone morphogenetic protein-4 induced cardiomyocyte apoptosis through activating Akt.
Xing Y; Yang D; Lu J; Dong DL
Biochem Biophys Res Commun; 2015 Jan; 456(2):605-9. PubMed ID: 25490386
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-4 induces upregulation of Cav3.1 Ca²⁺ channels in HL-1 atrial myocytes.
Hu CW; Li Q; Zhang Y; Li YH; Jiang HC; Liu MY; Li SL; Han W; Dong DL
Pflugers Arch; 2014 Nov; 466(11):2049-57. PubMed ID: 24510064
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-4 contributes to the down-regulation of Kv4.3 K+ channels in pathological cardiac hypertrophy.
Sun B; Sheng Y; Huo R; Hu CW; Lu J; Li SL; Liu X; Wang YC; Dong DL
Biochem Biophys Res Commun; 2013 Jul; 436(4):591-4. PubMed ID: 23747723
[TBL] [Abstract][Full Text] [Related]
7. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea.
Mohan RR; Kim WJ; Mohan RR; Chen L; Wilson SE
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2626-36. PubMed ID: 9856772
[TBL] [Abstract][Full Text] [Related]
9. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
[TBL] [Abstract][Full Text] [Related]
10. DAN (NBL1) specifically antagonizes BMP2 and BMP4 and modulates the actions of GDF9, BMP2, and BMP4 in the rat ovary.
Hung WT; Wu FJ; Wang CJ; Luo CW
Biol Reprod; 2012 May; 86(5):158, 1-9. PubMed ID: 22357543
[TBL] [Abstract][Full Text] [Related]
11. BMP2, BMP4, noggin, BMPRIA, BMPRIB, and BMPRII are differentially expressed in the adult rat spinal cord.
Miyagi M; Mikawa S; Sato T; Hasegawa T; Kobayashi S; Matsuyama Y; Sato K
Neuroscience; 2012 Feb; 203():12-26. PubMed ID: 22202460
[TBL] [Abstract][Full Text] [Related]
12. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin is upregulated in cardiomyocytes during cardiac hypertrophy and prevents the progression of contractile dysfunction.
Li YH; Chung HC; Luo CY; Chao TH; Shyu KG; Shi GY; Wu HL
J Card Fail; 2010 Dec; 16(12):980-90. PubMed ID: 21111988
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway.
Pachori AS; Custer L; Hansen D; Clapp S; Kemppa E; Klingensmith J
J Mol Cell Cardiol; 2010 Jun; 48(6):1255-65. PubMed ID: 20096288
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes.
Guo J; Sabri A; Elouardighi H; Rybin V; Steinberg SF
Circ Res; 2006 Dec; 99(12):1367-75. PubMed ID: 17110596
[TBL] [Abstract][Full Text] [Related]
19. Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy.
Buss SJ; Riffel JH; Malekar P; Hagenmueller M; Asel C; Zhang M; Weiss C; Katus HA; Hardt SE
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H420-30. PubMed ID: 22058151
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
